START FREE TRIAL

The LENS Index Just Added Three Names. None of Them Are Chips.

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

Three signals. One portfolio entry and two Watch List additions. That is what happened inside the LENS Index this week, and each one deserves a proper explanation.

The short version first. The AI trade is increasingly crowded. Capital has been flooding into semiconductors for the better part of a year. What the screeners keep surfacing is names that got left behind during that flood. This week, four separate screeners caught three distinct opportunities in sectors most analysts have stopped paying attention to. Two went to the Watch List. One went straight into the portfolio.

Here is the current LENS state before we get into the names.

MetricValueNotesLast Updated
Active Positions8 / 307 AI/tech + PODD (life sciences) + GEV (industrials)14-Jul-26
Cash Deployed37%Added GEV CORE 4% on Jul1414-Jul-26
Cash Reserve63%Minimum 15% maintained at all times14-Jul-26
Performance Since Launch+3.45%S&P: +1.15% | Alpha: +2.30% (as of Jul13)13-Jul-26
Alpha Generated+2.30%All prices user-confirmed from Robinhood13-Jul-26
Portfolio Beta0.671vs S&P 500 | 33 obs13-Jul-26
Max Drawdown-2.5%Jun1 peak to Jun5 trough13-Jul-26
Sharpe Ratio (Prelim.)1.49Annualized, 33 obs, rf=3.5%13-Jul-26
GEV EntryJul 14, 2026Article publication = entry event. CORE 4%. $1,042.60.14-Jul-26
InceptionMay 22, 2026DELL pre-mortem. Warsh sworn in same day.Fixed
BenchmarkS&P 500 Total ReturnOutperform on risk-adjusted basisFixed
StrategyNarrative DisruptionLong-only, large-cap, max 30 positionsFixed
DirectionLong OnlySubscribe to access all positionsFixed

All three names, the full reasoning behind each, and what we are watching for next are below the paywall…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Kenvue Tylenol Lawsuits Cloud $48.7 Billion Deal

Kenvue (NYSE:KVUE) woke up on July 13 with an...

Netflix Earnings Preview Q2: Can Live Programming Sustain Growth?

Netflix reports Q2 earnings after the market closes on...

Apple vs OpenAI Lawsuit: Can AI Hardware Threaten iPhone Era?

Apple (NASDAQ:AAPL) is not acting like a company whose...

TSMC Earnings Preview: Can Thursday Justify $2 Trillion?

Taiwan Semiconductor Manufacturing Company (NYSE:TSM) is about to give...

Tesla Q2 Earnings: Robotaxis, Optimus & The AI Reality Check

Tesla (NASDAQ:TSLA) heads into Tesla Q2 Earnings on July...

Related Articles

Kenvue Tylenol Lawsuits Cloud $48.7 Billion Deal

Kenvue (NYSE:KVUE) woke up on July 13 with an...

Netflix Earnings Preview Q2: Can Live Programming Sustain Growth?

Netflix reports Q2 earnings after the market closes on...

Apple vs OpenAI Lawsuit: Can AI Hardware Threaten iPhone Era?

Apple (NASDAQ:AAPL) is not acting like a company whose...

TSMC Earnings Preview: Can Thursday Justify $2 Trillion?

Taiwan Semiconductor Manufacturing Company (NYSE:TSM) is about to give...

Tesla Q2 Earnings: Robotaxis, Optimus & The AI Reality Check

Tesla (NASDAQ:TSLA) heads into Tesla Q2 Earnings on July...

Netflix Live TV Bundles Could Rebuild The Cable Box

Netflix (NASDAQ:NFLX) built its empire by freeing viewers from...

Smucker Hostess Deal Faces Reality After Twinkie Misstep

The J. M. Smucker Company (NYSE:SJM) thought it had...

Apple’s $30B Broadcom Deal Tests U.S. iPhone Story

Apple (NASDAQ:AAPL) just handed investors, politicians, and iPhone fans...
spot_img

Related Articles

Popular Categories

spot_imgspot_img